Coronary artery bypass graft surgery (CABG) for patients with diabetes and multivessel coronary artery disease: Identifying patients who would benefit with CABG and understanding the potential mechanisms involved

Kevin L. Greason, Hartzell V. Schaff

Research output: Contribution to journalReview article

1 Scopus citations

Abstract

Treatment of diabetic patients with multivessel coronary artery disease is controversial. This paper reviews pertinent literature on surgical revascularization with emphasis on which patients benefit from therapy. Recent studies of medical, percutaneous, and surgical therapies have added greatly to our understanding of the treatment of diabetic patients with coronary artery disease. Randomized trials show no advantage with prophylactic percutaneous coronary intervention over medical therapy. However, in patients with more severe three-vessel disease, coronary artery bypass graft surgery (CABG) improved outcomes with respect to reduced myocardial infarction events and cardiac death as compared with medical therapy. In addition, rates of late myocardial infarction and mortality were significantly lower in patients treated with CABG compared with those who received drug-eluting stents. Although the need for subsequent revascularization with drug-eluting stents is reduced compared with angioplasty and bare-metal stents, the rate is still higher than that associated with CABG. CABG reduces risks of myocardial infarction, cardiac death, and need for repeat revascularization in diabetic patients with severe, multivessel coronary artery disease.

Original languageEnglish (US)
Pages (from-to)402-406
Number of pages5
JournalCoronary Artery Disease
Volume21
Issue number7
DOIs
StatePublished - Nov 1 2010

Keywords

  • coronary artery bypass graft
  • coronary artery disease
  • diabetes
  • medical therapy
  • percutaneous coronary intervention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Coronary artery bypass graft surgery (CABG) for patients with diabetes and multivessel coronary artery disease: Identifying patients who would benefit with CABG and understanding the potential mechanisms involved'. Together they form a unique fingerprint.

  • Cite this